Health Canada Authorizes Moderna Phase 1 Trial for Ebola mRNA Vaccine
Health Canada has authorized Moderna to begin a Phase 1 clinical trial for an mRNA vaccine targeting the Bundibugyo strain of Ebola, making Canada the second country to test a vaccine against the outbreak driving a public health emergency in the Democratic Republic of Congo. Canada has granted regulatory authorization to US pharmaceutical giant Moderna … Read more